evidence table

Cocoa Flavanol Blood Pressure Meta-Analysis Evidence Table

Structured evidence table for Cocoa Flavanol Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Cocoa Flavanol Blood Pressure Meta-Analysis1 2 3 4 5 Metabolic syndrome (MetS) is characterized by the coexistence of cardiovascular risk factors and metabolic disorders, such as hypertension, insulin resistance, dyslipidemias – elevated triglyceride levels and reduced HDL levels – and increased waist circumference [,].1Gomes Chagas Amanda (2026)The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis
Cocoa Flavanol Blood Pressure Meta-AnalysisThe presence of MetS is a risk factor for other conditions, particularly increasing the risk of developing type 2 diabetes (DM2) by five times and the risk of cardiovascular diseases by three times [].1Gomes Chagas Amanda (2026)The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis
Cocoa Flavanol Blood Pressure Meta-AnalysisIt may be the result from a combination of genetic factors, dietary profile, and physical inactivity [].1Gomes Chagas Amanda (2026)The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis
Cocoa Flavanol Blood Pressure Meta-AnalysisCardiovascular diseases and metabolic dysfunction-associated steatotic liver disease (MASLD) are increasing sharply worldwide and share overlapping pathophysiological pathways, including oxidative stress, inflammation, hyperglycemia, obesity, dyslipidemia, and hypertension.4Tomaru JM (2026)Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.
Cocoa Flavanol Blood Pressure Meta-AnalysisBased on these properties, this narrative review uniquely integrates evidence on chocolate's effects on both cardiovascular and hepatic health, exploring shared mechanisms and clinical implications.4Tomaru JM (2026)Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.
Cocoa Flavanol Blood Pressure Meta-AnalysisEvidence from clinical studies suggests that chocolate modulates nitric oxide bioavailability and NADPH oxidase activity.4Tomaru JM (2026)Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.
Cocoa Flavanol Blood Pressure Meta-AnalysisDark chocolate, rich in cocoa flavanols such as epicatechin and catechin, exhibits antioxidant and anti-inflammatory effects.4Tomaru JM (2026)Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.
topicCocoa Flavanol Blood Pressure Meta-Analysis
claim1 2 3 4 5 Metabolic syndrome (MetS) is characterized by the coexistence of cardiovascular risk factors and metabolic disorders, such as hypertension, insulin resistance, dyslipidemias – elevated triglyceride levels and reduced HDL levels – and increased waist circumference [,].
evidence level1
citationGomes Chagas Amanda (2026)
sourceThe effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis
topicCocoa Flavanol Blood Pressure Meta-Analysis
claimThe presence of MetS is a risk factor for other conditions, particularly increasing the risk of developing type 2 diabetes (DM2) by five times and the risk of cardiovascular diseases by three times [].
evidence level1
citationGomes Chagas Amanda (2026)
sourceThe effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis
topicCocoa Flavanol Blood Pressure Meta-Analysis
claimIt may be the result from a combination of genetic factors, dietary profile, and physical inactivity [].
evidence level1
citationGomes Chagas Amanda (2026)
sourceThe effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis
topicCocoa Flavanol Blood Pressure Meta-Analysis
claimCardiovascular diseases and metabolic dysfunction-associated steatotic liver disease (MASLD) are increasing sharply worldwide and share overlapping pathophysiological pathways, including oxidative stress, inflammation, hyperglycemia, obesity, dyslipidemia, and hypertension.
evidence level4
citationTomaru JM (2026)
sourceBeyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.
topicCocoa Flavanol Blood Pressure Meta-Analysis
claimBased on these properties, this narrative review uniquely integrates evidence on chocolate's effects on both cardiovascular and hepatic health, exploring shared mechanisms and clinical implications.
evidence level4
citationTomaru JM (2026)
sourceBeyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.
topicCocoa Flavanol Blood Pressure Meta-Analysis
claimEvidence from clinical studies suggests that chocolate modulates nitric oxide bioavailability and NADPH oxidase activity.
evidence level4
citationTomaru JM (2026)
sourceBeyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.
topicCocoa Flavanol Blood Pressure Meta-Analysis
claimDark chocolate, rich in cocoa flavanols such as epicatechin and catechin, exhibits antioxidant and anti-inflammatory effects.
evidence level4
citationTomaru JM (2026)
sourceBeyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.

Learn next

Related evidence and supplement guides

SupplementBerberinePlant alkaloid with clinical evidence rivalling metformin for blood glucose control and lipid ma...GuideCocoa Flavanol Blood Lipids Meta-analysis: What the Evidence SaysCocoa Flavanol Blood Lipids Meta-analysis has 2 source documents in the current Migaku evidence...GuideCacao Flavanol Blood Pressure Meta-analysis: What the Evidence SaysCacao Flavanol Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidenc...GuideCacao Flavanols Blood Pressure Meta-analysis: What the Evidence SaysCacao Flavanols Blood Pressure Meta-analysis has 2 source documents in the current Migaku eviden...GuideBlueberry Blood Pressure Meta-analysis: What the Evidence SaysBlueberry Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence dat...AnswerDoes Cocoa Flavanol Blood Lipids Meta-Analysis work?Cocoa Flavanol Blood Lipids Meta-Analysis has evidence relevant to strength of evidence and what...AnswerIs Cocoa Flavanol Blood Lipids Meta-Analysis safe?Cocoa Flavanol Blood Lipids Meta-Analysis has evidence relevant to safety, limits, and clinician...AnswerWhat does the evidence say about Cocoa Flavanol Blood Lipids Meta-Analysis?Cocoa Flavanol Blood Lipids Meta-Analysis has evidence relevant to benefits, uncertainty, and pr...

Source documents

  1. The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis
  2. Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.